InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Mayer Eldon C. III, Executive. Insider active across 1 company, notably Eiger BioPharmaceuticals, Inc.. Aggregated, 4 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €18k. Activity tracked since 7 January 2022. The latest transaction was disclosed on 17 March 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mayer Eldon C. III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,520 shares@ US$1.0710.3% of flowCommon StockSEC:0001140361-23-012884:0
1,657 shares@ US$5.597338.3% of flowCommon StockSEC:0001567619-22-006947:0
16,000 shares0Common StockSEC:0001140361-22-009260:0
1,560 shares@ US$4.950130.9% of flowCommon StockSEC:0001567619-22-001050:0
4 of 4 declarations
About Mayer Eldon C. III
Eldon C. Mayer III is a former Vice President and Chief Commercial Officer at Eiger BioPharmaceuticals, Inc. In this role, he was responsible for the company's commercial strategy and business development. His experience in the biopharmaceutical sector allowed him to lead initiatives aimed at strengthening the company's market position.
